Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07665528Recruiting
Open-label trial of botulinum toxin type A in chronic anal fissure (CAF) (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: Fissure Healing Rate at 3 months. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07665528.